GenapSys Raises up to $75M in Debt Funding, Signs on More Than 25 Distributors

Feb 06, 2020

|

NEW YORK – Sequencing technology company GenapSys said on Thursday that it has raised up to $75 million in debt funding from Oxford Financing and has signed deals with more than 25 distributors worldwide.

The debt funding will go toward the company's commercialization activities as it is launching its sequencing platform globally.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Masterpiece Microbiome

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

High Numbers Reported for Russian Vaccine

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Limited Trust

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Featured White Papers

Epigenetics & DNA Methylation

Protein Biomarkers that Identify Responders and Non-Responders to Immunotherapy for Malignant Melanoma

Planning Your Lab-Developed Test Validation Experiments

Validation of NGS-Based Laboratory-Developed Testing

Dec

02

Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec

03

Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.

Dec

10

Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology.

Menu

GenapSys Raises up to $75M in Debt Funding, Signs on More Than 25 Distributors

To read the full story....

Breaking News

Molecular Changes Wrought by Spaceflight Explored in Newly Published Studies

Recurrent SARS-CoV-2 Virus Mutations Do Not Increase Transmissibility, Study Finds

Somalogic Closes $121M Series A Funding

Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

The Scan

Masterpiece Microbiome

High Numbers Reported for Russian Vaccine

Limited Trust

Nucleic Acids Research Papers on Aging Atlas, Human Metagenomes, Drug Repositioning

Featured White Papers

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

What's Popular?

Recurrent SARS-CoV-2 Virus Mutations Do Not Increase Transmissibility, Study Finds

Austrian SARS-CoV-2 Genomic Study Delivers Details for Superspreader Events Early in Pandemic

Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves

Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs

Sponsorships